Berlin, Germany

Beate Ludescher

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 7.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Beate Ludescher: Innovator in Pharmaceutical Treatments

Introduction

Beate Ludescher is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of chronic progressive multiple sclerosis. With a total of 4 patents to her name, her work is recognized for its innovative approaches to medical treatments.

Latest Patents

One of her latest patents focuses on the use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of chronic progressive multiple sclerosis. This invention relates to the use of this compound, or related compounds, for treating both primary and secondary progressive multiple sclerosis. Another notable patent involves a new crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, which includes methods for its production and pharmaceutical preparations containing this form.

Career Highlights

Beate Ludescher is currently associated with Metriopharm AG, where she continues to advance her research and development efforts. Her work has been instrumental in creating effective pharmaceutical solutions for complex medical conditions.

Collaborations

Throughout her career, Beate has collaborated with notable professionals in her field, including Wolfgang Brysch and Thomas Martin. These partnerships have contributed to the success and impact of her inventions.

Conclusion

Beate Ludescher stands out as an influential inventor in the pharmaceutical industry, with her innovative patents paving the way for new treatments in chronic progressive multiple sclerosis. Her dedication to research and collaboration continues to drive advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…